[
  {
    "title": "Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped",
    "published": 1742834641,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Was Jim Cramer Right About Eli Lilly and Company (LLY)?",
    "published": 1742831940,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble.",
    "published": 1742830651,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Eli Lilly Could See Higher Q1 Sales for Zepbound, UBS Says",
    "published": 1742827290,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Is Eli Lilly and Company (LLY) The Best Healthcare Dividend Stock to Invest in?",
    "published": 1742822137,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains",
    "published": 1742820300,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Novo adds to obesity drug pipeline via $200M deal with China-based biotech",
    "published": 1742817720,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Market Sell-Off: Can Buying These 3 \"Safe\" Stocks Today Set You Up for Life?",
    "published": 1742817600,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "J&J to Invest $55B in United States to Boost Manufacturing, R&D",
    "published": 1742812140,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Lilly, Novo expand DTC reach of obesity meds after compound win",
    "published": 1742803200,
    "posting_price": 845.32000732,
    "close_price": 860.07000732,
    "percent_change": 1.74490132
  },
  {
    "title": "Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly",
    "published": 1742719380
  },
  {
    "title": "Is Eli Lilly and Company\u00a0(LLY) The Best Robinhood Stock to Buy According to Analysts?",
    "published": 1742665388
  },
  {
    "title": "Johnson & Johnson is the latest pharma giant to court Trump with new investment plans",
    "published": 1742582460,
    "posting_price": 837.79998779,
    "close_price": 837.57000732,
    "percent_change": -0.02745052
  },
  {
    "title": "Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz",
    "published": 1742573786,
    "posting_price": 837.79998779,
    "close_price": 837.57000732,
    "percent_change": -0.02745052
  },
  {
    "title": "Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell?",
    "published": 1742570262,
    "posting_price": 837.79998779,
    "close_price": 837.57000732,
    "percent_change": -0.02745052
  },
  {
    "title": "Eli Lilly launches weight-loss drug Mounjaro in India, Reuters says",
    "published": 1742566627,
    "posting_price": 837.79998779,
    "close_price": 837.57000732,
    "percent_change": -0.02745052
  },
  {
    "title": "3 of Goldman Sachs' best investing tips for currently volatile markets",
    "published": 1742563852,
    "posting_price": 837.79998779,
    "close_price": 837.57000732,
    "percent_change": -0.02745052
  },
  {
    "title": "The Mag 7 Are Dead Money. 6 \u2018Megacap\u2019 Stocks to Buy Instead.",
    "published": 1742558940,
    "posting_price": 837.79998779,
    "close_price": 837.57000732,
    "percent_change": -0.02745052
  },
  {
    "title": "Factbox-Lilly's weight-loss drug launch in India to energize rivals eyeing mega market",
    "published": 1742486795,
    "posting_price": 839.0300293,
    "close_price": 842.57000732,
    "percent_change": 0.42191315
  },
  {
    "title": "5 Reasons It's Not Too Late to Buy Eli Lilly Stock",
    "published": 1742462700,
    "posting_price": 839.0300293,
    "close_price": 842.57000732,
    "percent_change": 0.42191315
  },
  {
    "title": "Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk",
    "published": 1713197290,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "Jim Cramer is Recommending These 10 Stocks in April",
    "published": 1713192174,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Eli Lilly",
    "published": 1713181440,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "Nvidia is the No. 1 S&P 500 growth stock in this screen. See which other companies joined or left the list.",
    "published": 1713181140,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), McKesson (MCK)",
    "published": 1713180060,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm",
    "published": 1713175200,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead",
    "published": 1713174360,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA), PolyPid (PYPD) and Eli Lilly & Co (LLY)",
    "published": 1713151260,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "BTIG Research Predicts Over 118% Rally for These 3 Stocks",
    "published": 1713144300,
    "posting_price": 755.16359948,
    "close_price": 745.92364502,
    "percent_change": -1.22356989
  },
  {
    "title": "Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down",
    "published": 1713070860
  },
  {
    "title": "Jim Cramer\u2019s 10 Favorite Healthcare Stock Picks in 2024",
    "published": 1713025104
  },
  {
    "title": "3 Magnificent Stocks That Could Double or More by 2030",
    "published": 1713012420
  },
  {
    "title": "It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?",
    "published": 1712995200
  },
  {
    "title": "Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says",
    "published": 1712952411,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Shark Tank's Mark Cuban speaks out on weight-loss drugs",
    "published": 1712948547,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock",
    "published": 1712926816,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating",
    "published": 1712924640,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March",
    "published": 1712924520,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "LLY, NVO: Obesity Drugs May Help with Parkinson\u2019s",
    "published": 1712922840,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "European regulator concludes no suicide link to obesity drugs",
    "published": 1712922300,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "GLP-1s benefit Parkinson\u2019s: Barclays sees implications across biopharma",
    "published": 1712919780,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding Pharmacy",
    "published": 1712919660,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says",
    "published": 1712915040,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Ozempic, similar weight-loss drugs don\u2019t increase suicide risk: EU regulator",
    "published": 1712914620,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Leerink sees 'marginal' Q1 downside for Lilly amid supply constraints",
    "published": 1712912160,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Obesity-drug power couple Novo Nordisk and Eli Lilly still have room to run, analysts say",
    "published": 1712909640,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Popular weight-loss drug doesn\u2019t increase suicide risk, EU regulator says",
    "published": 1712902560,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "No link between weight loss drugs and suicidal thoughts, EU regulator concludes",
    "published": 1712902140,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "7 A-Rated Aggressive Biotech Stocks to Bet On in 2024",
    "published": 1712900640,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027",
    "published": 1712899740,
    "posting_price": 754.66682786,
    "close_price": 746.7880249,
    "percent_change": -1.04401077
  },
  {
    "title": "Roche, Eli Lilly gain FDA breakthrough device tag for Alzheimer's blood test",
    "published": 1712813160,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Drugmakers look to alternative suppliers after draft U.S. legislation, FT says",
    "published": 1712812980,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Roche announces U.S. FDA granted BDD to its Elecsys pTau217 assay",
    "published": 1712812620,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024",
    "published": 1712806380,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next Milestone",
    "published": 1712804220,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Blood test by Roche and Eli gets FDA breakthrough device designation",
    "published": 1712802840,
    "posting_price": 754.87548248,
    "close_price": 754.68670654,
    "percent_change": -0.02500756
  },
  {
    "title": "Eli Lilly (LLY) Increases Despite Market Slip: Here's What You Need to Know",
    "published": 1712785519,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild",
    "published": 1712778060,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "Insiders are Piling into These 10 Healthcare Stocks in 2024",
    "published": 1712777442,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?",
    "published": 1712755620,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "ClearBridge Appreciation Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712753700,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "Eli Lilly & Co: Strong Buy Rating on Robust \u2018Diabesity\u2019 Portfolio and Key Product Outperformance",
    "published": 1712724420,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "published": 1712720100,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies",
    "published": 1712716080,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "Top 10 best performing S&P 500 health care stocks of 2024",
    "published": 1712714220,
    "posting_price": 746.43033782,
    "close_price": 757.06121826,
    "percent_change": 1.42422942
  },
  {
    "title": "10 Health Care Stocks With Whale Alerts In Today's Session",
    "published": 1712666400,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Eli Lilly launches construction of $2.5B plant to meet obesity drug demand",
    "published": 1712664720,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Cantor starts Structure at overweight, sees positive data for GLP-1 drug",
    "published": 1712662980,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "11 Best Biotech ETFs To Buy",
    "published": 1712662637,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Novo Nordisk: The Moat Won't Last Forever",
    "published": 1712662210,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up",
    "published": 1712660520,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "3 High-Growth Biotech Stocks Investors Shouldn\u2019t Sleep On in April",
    "published": 1712660400,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead.",
    "published": 1712659500,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
    "published": 1712658900,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Jim Cramer Stands By Nvidia And Eli Lilly Despite Market Dips, Says 'Terrific Time To Take Some Profits'",
    "published": 1712655420,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Madrigal announces US launch of NASH/MASH drug Rezdiffra",
    "published": 1712653680,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Eli Lilly and Co's Options: A Look at What the Big Money is Thinking",
    "published": 1712652420,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Amphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of Opportunity",
    "published": 1712646540,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth",
    "published": 1712641773,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "MarketMasterAI\u2019s Top 500 Stocks: April 2024",
    "published": 1712633160,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Cabot Wealth\u2019s Top Ten list of stocks",
    "published": 1712627460,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Cabot\u2019s Top Ten list of stocks",
    "published": 1712625000,
    "posting_price": 772.6202062,
    "close_price": 752.35186768,
    "percent_change": -2.62332493
  },
  {
    "title": "Weight-loss drug shortage result of 'unprecedented demand'",
    "published": 1712612123,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "Healthcare ETFs for the Weight-Loss Drug Boom & Beyond",
    "published": 1712604840,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "2 Growth Stocks to Buy Hand Over Fist in April",
    "published": 1712579400,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "Zacks Market Edge Highlights: VICI Properties, KeyCorp, Meta Platforms, ExxonMobil and Eli Lilly",
    "published": 1712578200,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "Trial shows Wegovy can ease heart failure symptoms",
    "published": 1712578140,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "ProfoundBio Discovers The Joys Of Having A Wealthy Owner",
    "published": 1712573460,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "This 1 Number May Ensure Eli Lilly's Dominance in the Weight Loss Drug Market",
    "published": 1712572200,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It.",
    "published": 1712570100,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "Lilly - Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance on risk of heart failure hospitalization and death in adults following a heart attack",
    "published": 1712561231,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Ionis Pharmaceuticals (IONS) and Medtronic (MDT)",
    "published": 1712551860,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "Eli Lilly research costs rise but Jardiance trial disappoints",
    "published": 1712551800,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "EMA to discuss possible link between GLP-1s, suicidal thoughts: report",
    "published": 1712542500,
    "posting_price": 779.95248064,
    "close_price": 772.27233887,
    "percent_change": -0.98469355
  },
  {
    "title": "Could This New Development Soon Buoy Eli Lilly and Novo Nordisk Stock?",
    "published": 1712488500
  },
  {
    "title": "The biggest S&P stocks have to do the heavy earnings lifting (again) - Goldman",
    "published": 1712484600
  },
  {
    "title": "10 Best Weight Loss Drug Stocks to Buy Now",
    "published": 1712450873
  },
  {
    "title": "Jim Cramer is Bearish On These 10 Stocks in April",
    "published": 1712413222
  },
  {
    "title": "Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock",
    "published": 1712406600
  },
  {
    "title": "Is it Too Late to Buy Viking Therapeutics Stock?",
    "published": 1712403900
  },
  {
    "title": "Eli Lilly and : Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance\u00ae (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack",
    "published": 1712397246
  },
  {
    "title": "Eli Lilly and : Q1 Earnings 2024 Estimated Acquired IPR&D And Development Milestone Charges",
    "published": 1712334262,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "BME: Trading At A Historical Discount To NAV",
    "published": 1712317631,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "Viking Therapeutics Stock (NASDAQ:VKTX): Analysts Stay Bullish on 2024\u2019s Top Mid-Cap",
    "published": 1712317260,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds",
    "published": 1712316540,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Pfizer (PFE), Eli Lilly & Co (LLY)",
    "published": 1712316060,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "Eli Lilly and Co Options Trading: A Deep Dive into Market Sentiment",
    "published": 1712309640,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "How a Biden-Trump rematch can keep healthcare ETFs afloat this election year",
    "published": 1712294760,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "Lilly to record $111M pre-tax IPR&D charges in Q1",
    "published": 1712293380,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "Eli Lilly sees Q1 pre-tax IPR&D charges of roughly $111M",
    "published": 1712287860,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "Traders Rethink Interest Rate Cuts, Labor Market Heats Up, Oil Prices Quietly Reach 6-Month High: This Week In The Markets",
    "published": 1712287560,
    "posting_price": 760.52868618,
    "close_price": 779.14776611,
    "percent_change": 2.44817589
  },
  {
    "title": "How to Create a Stock Portfolio that Pays $100 a Month",
    "published": 1712264700,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "3 Growth Stocks with Even Greater Potential Than the Magnificent 7",
    "published": 1712237580,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed",
    "published": 1712237410,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "10 Health Care Stocks Whale Activity In Today's Session",
    "published": 1712234280,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Baird puts Inspire on top idea list, sees limited impact by GLP-1s",
    "published": 1712233080,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?",
    "published": 1712220900,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Spring 2024 Snapshot Of The S&P 500's Market Cap",
    "published": 1712217900,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Eli Lilly & Co (LLY), UnitedHealth (UNH)",
    "published": 1712212860,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "7 A-Rated Stocks to Buy in April",
    "published": 1712210400,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.",
    "published": 1712206800,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?",
    "published": 1712196187,
    "posting_price": 776.49502316,
    "close_price": 763.12194824,
    "percent_change": -1.72223575
  },
  {
    "title": "Erste Group Upgrades Eli Lilly and (LLY)",
    "published": 1712178550,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Why Eli Lilly Stock Topped the Market Today",
    "published": 1712176262,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Verve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls",
    "published": 1712166000,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says",
    "published": 1712156728,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "UPDATE 2-Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says",
    "published": 1712156586,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Novo Nordisk's Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China",
    "published": 1712148060,
    "posting_price": 760.74733545,
    "close_price": 770.98083496,
    "percent_change": 1.34519032
  },
  {
    "title": "Dow Jones Futures: Market Slides But Holds Key Levels; Tesla Skids As Meta Eyes Buy Point",
    "published": 1712091226,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Verve Therapeutics Stock Remains A Hold After VERVE-101 Enrollment Pause",
    "published": 1712145465,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "What You Missed On Wall Street This Morning",
    "published": 1712143200,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Zepbound shortage: Eli Lilly's weight-loss drug in limited availability through April-end",
    "published": 1712142420,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Some doses of Lilly's Zepbound in short supply through April-end, US FDA says",
    "published": 1712142186,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Some doses of Lilly's Zepbound in limited availability, US FDA says",
    "published": 1712141117,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Unpacking the Latest Options Trading Trends in Eli Lilly and Co",
    "published": 1712138820,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Lilly weight loss drug on limited supply through April, FDA says",
    "published": 1712137980,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "FDA says Eli Lilly's Zepbound at limited availability through April",
    "published": 1712137740,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Why Nvidia Could Become The Largest Company, But Not For Long",
    "published": 1712136629,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Early notable gainers among liquid option names on April 3rd",
    "published": 1712134560,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Erste Group gets more bullish on Eli Lilly, upgrades shares",
    "published": 1712127300,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Novo\u2019s Ozempic to face copycats as Chinese firm seeks biosimilar nod",
    "published": 1712124180,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Glaukos (GKOS) and Omnicell (OMCL)",
    "published": 1712119260,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "What You Missed On Wall Street On Wednesday",
    "published": 1712114880,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "The 3 Best Healthcare Stocks to Buy in April 2024",
    "published": 1712114100,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly Struggles To Keep Pace With Mounjaro, Zepbound Demand: 'Currently Unavailable' On Amazon Pharmacy",
    "published": 1712113800,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Noteworthy Wednesday Option Activity: LLY, RH, IBM",
    "published": 1712111640,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Costco Long Known For Rotisserie Chicken And Hot Dogs Counters Junk Food With Weight Loss Plan To Help You Shed Those Extras",
    "published": 1712111100,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note",
    "published": 1712094318,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Stocks Bend As Yields Rise; Meta Platforms, Uber, Eli Lilly In Focus",
    "published": 1712090144,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Some doses of Lilly's Mounjaro in tight supply through April, US FDA says",
    "published": 1712074927,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "UPDATE 1-Some doses of Lilly's Mounjaro in tight supply through April, US FDA says",
    "published": 1712074665,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "FDA website shows limited availability of some doses of Lilly's Mounjaro through April",
    "published": 1712070327,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly\u2019s Ozempic Competitors Face Risks. Why the Stock Has More Upside.",
    "published": 1712062440,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action",
    "published": 1712058354,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts",
    "published": 1712056740,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Outperforming ETF manager names a potential \u201850-bagger\u2019 in the stock market",
    "published": 1712055840,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly Stock Navigates Weight-Loss Drug Competition With Technical Resilience",
    "published": 1712054700,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "The Zacks Analyst Blog Highlights Apple, NVIDIA, Eli Lilly, American Tower and McKesson",
    "published": 1712050620,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Is It Too Late to Buy Eli Lilly Stock?",
    "published": 1712049000,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Verve drops after pausing trial enrollments for lead asset",
    "published": 1712040720,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Verve drops after pausing enrollments in trial for lead asset",
    "published": 1712039820,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Viking Therapeutics: Future Weight Loss Heavyweight?",
    "published": 1712037671,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Buy Amazon Stock Now for Continued Growth and Diversification",
    "published": 1712034420,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly price target raised by $220 at Citi, here's why",
    "published": 1712032500,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Eli Lilly Poised for Market Dominance Amid Positive orforglipron Trial Results and Legislative Tailwinds",
    "published": 1712030880,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "5 Healthcare Stocks to Buy for 2024",
    "published": 1712028660,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Citigroup Pounds the Table on Eli Lilly Stock",
    "published": 1712023860,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race",
    "published": 1712022900,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Citi Monitors Competitive Threats To Eli Lilly, Says It Is Positioned To Maintain Leadership And Expand",
    "published": 1712022180,
    "posting_price": 750.19587564,
    "close_price": 759.02850342,
    "percent_change": 1.17737621
  },
  {
    "title": "Top Stock Reports for Apple, NVIDIA & Eli Lilly",
    "published": 1711996680,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1711976414,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "Missed the \"Magnificent Seven\"? Try Buying These 3 Forever Stocks Instead",
    "published": 1711976400,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "These are the most crowded stocks within each sector - BofA",
    "published": 1711974960,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "The least shorted S&P 500 stocks as a percentage of float - BofA",
    "published": 1711964940,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "Meet The \"Magnificent Seven\" of Healthcare Stocks",
    "published": 1711960200,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "ResMed price target raised by $9 at Needham, here's why",
    "published": 1711959600,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "What Analysts Are Saying About Eli Lilly and Co Stock",
    "published": 1711958700,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "Cytokinetics, Incorporated: Buyout Speculation Persists",
    "published": 1711951699,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "Eli Lilly & Co. stock underperforms Monday when compared to competitors",
    "published": 1711942560,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  },
  {
    "title": "20 Most Obese Countries in Asia",
    "published": 1711937740,
    "posting_price": 770.99084485,
    "close_price": 755.64056396,
    "percent_change": -1.99098096
  }
]